These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9222876)

  • 1. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages.
    Tomono S; Kawazu S; Kato N; Ono T; Ishii C; Ito Y; Shimizu M; Shimoyama M; Nakano T; Nakajima K
    J Atheroscler Thromb; 1994; 1(2):98-102. PubMed ID: 9222876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
    Saniabadi AR; Umemura K; Suzuki Y; Kondo K; Ikeda Y; Adachi M; Nakashima M
    Life Sci; 1998; 63(12):1065-74. PubMed ID: 9749829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
    Saniabadi AR; Umemura K; Shimoyama M; Adachi M; Nakano M; Nakashima M
    Thromb Haemost; 1997 May; 77(5):996-1001. PubMed ID: 9184417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of remnant-like particles from serum of diabetic patients, patients with ischemic heart disease and normal subjects.
    Tamura M; Tanaka A; Yui K; Nakajima K; Numano F
    Horm Metab Res; 1997 Aug; 29(8):398-402. PubMed ID: 9288578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.
    Nakajima K; Tanaka A
    Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial lipoprotein metabolism: VLDL vs chylomicrons.
    Nakajima K; Nakano T; Tokita Y; Nagamine T; Inazu A; Kobayashi J; Mabuchi H; Stanhope KL; Havel PJ; Okazaki M; Ai M; Tanaka A
    Clin Chim Acta; 2011 Jul; 412(15-16):1306-18. PubMed ID: 21531214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro.
    Knöfler R; Nakano T; Nakajima K; Takada Y; Takada A
    Thromb Res; 1995 Apr; 78(2):161-71. PubMed ID: 7482433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesis II: The majority of VLDL-apoB48 remnants in postprandial plasma are derived from the liver, not from the intestine.
    Nakajima K; Tokita Y; Tanaka A
    Clin Chim Acta; 2019 Mar; 490():12-16. PubMed ID: 30553860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant-like particles (RLP) from NIDDM patients with apolipoprotein E3/3 phenotype stimulate cholesteryl ester synthesis in human monocyte-derived macrophages.
    Saito M; Eto M; Okada M; Iwashima Y; Makino I
    Artery; 1996; 22(3):155-63. PubMed ID: 8893973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.
    Nakajima K; Saito T; Tamura A; Suzuki M; Nakano T; Adachi M; Tanaka A; Tada N; Nakamura H; Campos E
    Clin Chim Acta; 1993 Dec; 223(1-2):53-71. PubMed ID: 8143370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2007 Oct; 194(2):473-82. PubMed ID: 17045270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative reactivity of remnant-like lipoprotein particles (RLP) and low-density lipoprotein (LDL) to LDL receptor and VLDL receptor: effect of a high-dose statin on VLDL receptor expression.
    Imagawa M; Takahashi S; Zenimaru Y; Kimura T; Suzuki J; Miyamori I; Iwasaki T; Hattori H; Yamamoto TT; Nakano T; Nakajima K
    Clin Chim Acta; 2012 Feb; 413(3-4):441-7. PubMed ID: 22085424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
    Nakajima K; Tanaka A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.
    Gianturco SH; Bradley WA; Gotto AM; Morrisett JD; Peavy DL
    J Clin Invest; 1982 Jul; 70(1):168-78. PubMed ID: 6282937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aggregation of human blood platelets by remnant-like lipoprotein particles].
    Umemura K; Saniabadi AR
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):269-74. PubMed ID: 11215376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decrease of remnant like particle (RLP) in active pulmonary tuberculosis].
    Imaizumi T
    Kekkaku; 1998 Jan; 73(1):13-5. PubMed ID: 9494340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
    Watanabe N; Taniguchi T; Taketoh H; Kitagawa Y; Namura H; Yoneda N; Kurimoto Y; Yamada S; Ishikawa Y
    Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
    Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
    Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Searching for a new risk factor of sudden cardiac death].
    Takeichi S
    Nihon Hoigaku Zasshi; 1999 Nov; 53(3):255-75. PubMed ID: 10723958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.